CoChat

Adverse Reactions and Interactions with H2-Receptor Antagonists

Pension, J., Wormsley, K. G. · 1986 · Medical Toxicology

The DOI matches its Crossref record; 324 of the 326 references it cites were found in a registry or an index.

Abstract

Histamine H2-receptor antagonists have been used in the treatment of gastrointestinal diseases for more than a decade and during this period have become one of the most commonly prescribed groups of drugs in the world. The deserved popularity of the H2-receptor antagonists reflects, in part, their therapeutic efficacy, which has revolutionised the treatment of peptic ulcer disease. An equally, or more, important reason for the widespread use of H2-receptor antagonists is their remarkably low toxicity. We have attempted, in this review, to present a detailed account of the minor and more serious adverse reactions, while emphasising the low incidence of the former and the rarity of the latter. The toxicology of the H2-receptor antagonists is discussed under two main headings: adverse effects; and drug interactions. The latter category is potentially the more significant, since the frequent use of therapy with multiple drugs may give rise to drug interactions, some of which are serious and may even be lethal. These drug interactions occur especially in the gastrointestinal tract, the liver and the kidneys. Thus, the absorption of other drugs may be altered because the H2-receptor antagonists inhibit gastric secretion--an effect illustrated by ketoconazole, the absorption of which is reduced when given in combination with cimetidine. Very important drug interactions are caused by inhibition of the hepatic microsomal enzyme cytochrome P450 by some of the H2-receptor antagonists. T…

Overview

Integrity signals

Registry

Crossref · 10.1007/bf03259837

Cites

324 of 324 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 324 references

Research works printed but not linked: 34

  1. Aymard B, Aymard JP, Netter P, Legras B, Streiff F. Cytopenies sanguines associees a la prise de cimetidine. Therapie 39: 545–553, 1984
  2. Belaiche J, Zitoun J, Marquet J, Nurit Y, Yvart J. Effet de la ranitidine sur la secretion de facteur intrinseque gastrique et sur l’absorption de la vitamine B12. Gastroenterologie Clinique et Biologique 7: 381–384, 1983
  3. Bertaccini C, Coruzzi G. H2 receptor antagonists: side-effects and adverse effects. Italian Journal of Gastroenterology 16: 119–124, 1984
  4. Bertaccini G, Licchin L, Bonoldi C, Felder H, Debrilla G. Absence of.cholinergic-like activity of ranitidine on human salivary and lacrimal secretions. Italian Journal of Gastroenterology 13: 253–254, 1981
  5. Bianchi Porro G, Cheli R. Gynaecomastia and ranitidine. Italian Journal of Gastroenterology 16: 56, 1984
  6. Bianchi Porro G, Petrillo M, Recchia G. The safety of ranitidine: 1981–83 post-marketing surveillance experience in Italy. Clinical Trials Journal 22: 441–447, 1985a
  7. Braito E, Oberlechner R, Camberlato R, Amplatz S, Dobrilla G. Heart rate and blood pressure in non-cardiopathic volunteers receiving acute intravenous loads of H2-antagonists. Trial based on Holter-Edwards dynamic electrocardiography. Italian Journal of Gastroenterology 17: 176, 1985
  8. Buchanan KD, Spencer A, Ardill J, Kennedy TL. Hypergastrinaemia due to cimetidine. Gut 19: A437, 1978
  9. Cavallini G, Angelini G, Vaona B, Bovo P, Rosa B, et al. Ranitidine and Candida albicans. Italian Journal of Gastroenterology 15: 189, 1983
  10. Dabadie H, Lamouliatte H, Quinton A, Geniaux M. Syndrome de Lyell induit par la cimetidine. Gastroenterologie Clinique et Biologique 7: 425–426, 1983
  11. Dobrilla G, Coruzzi G, Bertaccini G, Carvallini G. Extragastric effect of ranitidine. Italian Journal of Gastroenterology 14: 55–56, 1982
  12. Dorr RT. Effects of H2 antagonists on highly-metabolized anti-cancer drugs. Gastroenterology 88: 1368, 1985
  13. Enzmann GD, Leonard JM, Paulsen CA, Rogers J. Effect of cimetidine on reproductive function in men. Clinical Research 29: 26A, 1981
  14. Hadas N, Wapnick S, Grosberg SJ, Sugaar S. Cimetidine induced mortality in experimental pancreatitis. Gastroenterology 76: 1148, 1979
  15. Hagenmüller F, Usadel KH, Schwedes U, Zeitler-Abu-Ishira A, Classen M. Ranitidin und Cimetidin: Untersuchungen Zur Gastralen Sekretionshemmung und Antiandrogenität. Innere Medizin 9: 347–352, 1982
  16. Hansen WE, Nehammer K. Inhibition of cholinesterases by oxmetidine. Gastroenterology 86: 1107, 1984
  17. Hayakawa A, Che K, Miyoshi A, Harawara S, Miwa T, et al. Properties of famotidine in relation to safety. Italian Journal of Gastroenterology 16: 174–176, 1984
  18. Hine KR, Holmes GKT, Milnes JP, Phillips A, Poynter D, et al. Microscopic examination of gastric biopsies from patients treated with ranitidine. Gastroenterology 82: 1085, 1982
  19. Leslie GB, Walker TF. A toxicological profile of cimetidine. In Burland WL & Simkins MA (Eds). Cimetidine — proceedings of the second international symposium on histamine H2 receptor antagonists, pp. 24–33, Excerpta Medica, Amsterdam, 1977
  20. Lombardo L. Hyperprolactinaemia: ranitidine revisited adverse effect. Italian Journal of Gastroenterology 17: 160, 1985
  21. McGonigle RJS, Williams LC, Amphlett GE, England RJ, Parsons V. The pharmacokinetics of ranitidine in renal disease. In Misiewicz JJ & Wormsley KG (Eds). The clinical use of ranitidine, pp. 41–46, Medicine Publishing Foundation, Oxford 1982
  22. Mantero F. Ranitidine and gynaecomastia. Italian Journal of Gastroenterology 17: 114, 1985
  23. Mavier P, Preaux AM, Delchier JC, Beauchant M, Dhumeaux D. Comparaison des effets de la cimetidine et de la ranitidine in vivo et in vitro sur le systeme enzymtique microsomal hepatique chez le rat. Gastroenterologie Clinique et Biologique 7: 244–250, 1983
  24. Miyoshi A, Muto V, Mori H, Miwa T, Nakazawa S, et al. Famotidine: summary of overall safety from Japanese clinical studies. Italian Journal of Gastroenterology 16: 177–178, 1984
  25. Pallone F, Paoluzi P, Marcheggiano A, Ripoli F, Carratu R. Cimetidine and duodenal ulcer associated gastritis. Italian Journal of Gastroenterology 12: 210–211, 1980
  26. Paradelis AG, Triantaphyllidis CJ, Stavrakis AO, Crassaris LG. Interaction of aminoglycoside antibiotics with H2-receptor blocking agents at the neuromuscular junctions. Drugs in Experimental and Clinical Research 10: 807–811, 1984
  27. Pasquali R, Corinaldesi R, Patrono D, Capelli M, Stanghellini V, et al. Effect ot intravenous ranitidine on serum prolactin (PRL): evidence for a sex difference. Gastroenterology 84: 1271, 1983
  28. Peden NR, Wormsley KG. Alleged impotence with ranitidine. Lancet 2: 798, 1983
  29. Simon B, Müller P, Dammann HG. Safety profile of ranitidine. In Riley AJ & Salmon PR (Eds). Ranitidine, pp 181–189, Excerpta Medica, Amsterdam, 1982
  30. Simon B, Müller P, Dammann HG. Cimetidine, Ranitidin und Famotidin: eine vergleichende Wertung. Innere Medizin 11: 81–84, 1984
  31. Tomioka K, Yamada T, Tachikawa S. Effects of famotidine (YM11170), an H2-receptor antagonist, on in vivo immediate and delayed type hypersensitivity reactions and antibody formation. Drugs under Experimental and Clinical Research 9: 881–889, 1983
  32. Vickers MR, Arlington SA, Jones C, Martin D, Melvin MA. The role of histamine in immune responses. In Torsoli A, Lucchelli PE, Brimblecombe RW (Eds). Further experience with H2-receptor antagonists in peptic ulcer disease and progress in histamine research, pp 311–326, Excerpta Medica, Amsterdam, 1980
  33. Willing RL, Whitehead R, Oldmeadow M, Mackinnon M. Cimetidine and duodenitis — a placebo controlled double blinded study of the effect of cimetidine on the endoscopic and histological appearances of duodenitic mucosa. Gastroenterology 78: 1291, 1980
  34. Wilson JA, Craig IF. Cimetidine, ranitidine and HDL-cholesterol. Gastroenterology 88: 1632, 1985

Cited by

Metadata

Authors
Pension, J., & Wormsley, K. G.
Affiliations
University of Dundee (GB)
Venue
Medical Toxicology
Published
1986-06
Volume
1
Issue
3
Pages
192-216
ISSN
0112-5966 (ISSN-L)
OpenAlex
W2465608970
Cited by
63
References
326
Citations by year
2024: 2 · 2023: 1 · 2022: 3 · 2021: 2 · 2020: 2 · 2019: 1 · 2018: 2 · 2017: 1 · 2016: 1 · 2014: 1 · 2013: 2 · 2012: 2
FWCI
4.94
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Medical Toxicology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
Keywords
H2 receptor antagonists, adverse drug reactions, drug interactions, cimetidine, ranitidine, ketoconazole, cytochrome P450 inhibition, drug metabolism, gastric acid secretion, drug absorption, renal tubular secretion, procainamide, quinidine, peptic ulcer, drug toxicity, gastrointestinal adverse effects, renal adverse effects
MeSH terms
Animals, Cardiovascular Diseases, Central Nervous System Diseases, Digestive System Diseases, Drug Interactions, Endocrine System Diseases, Hematologic Diseases, Histamine H2 Antagonists, Humans, Kidney Diseases, Skin Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.